Provided by Tiger Fintech (Singapore) Pte. Ltd.

CALIDI BIOTHERAPEUTICS INC

0.6960
-0.0174-2.44%
Post-market: 0.6924-0.0036-0.52%18:23 EDT
Volume:2.01M
Turnover:1.39M
Market Cap:25.28M
PE:-0.23
High:0.7421
Open:0.7421
Low:0.6527
Close:0.7134
Loading ...
Jan 16, 2024

Correspondence

Form CORRESP - Correspondence
Jan 16, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 08, 2024

Correspondence

Form CORRESP - Correspondence
Jan 08, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 08, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

Correspondence

Form CORRESP - Correspondence
Dec 12, 2023

Major Issues Report

Form 8-K - Current report
Dec 12, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 05, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2023

Major Issues Report

Form 8-K - Current report
Oct 28, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 16, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Oct 06, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 30, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]